Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK)
HKD 0.67
(0.0%)
HKD 0.67
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 199.48 Million | 46.49 Million | 665.29 Million | 227.13 Million | 1.41 Billion | 1.79 Billion |
| Net Income | -161.26 Million | -1.91 Billion | 416.5 Million | 473.38 Million | -2.75 Billion | 1.61 Billion |
| Depreciation & Amortization | 226.23 Million | 338.77 Million | 278.96 Million | 252.37 Million | 259.29 Million | 193.62 Million |
| Deferred income taxes | - | 134.45 Million | 412.69 Million | 311.66 Million | -126.97 Million | 93.14 Million |
| Stock-based compensation | 89.08 Million | 89.66 Million | 59.35 Million | 23.17 Million | 353 Thousand | 345 Thousand |
| Change in working capital | 111.1 Million | -224.11 Million | -472.04 Million | -334.83 Million | 126.61 Million | -93.49 Million |
| Other non-cash items | 121.42 Million | 1.62 Billion | -30.18 Million | -498.62 Million | 3.91 Billion | -20.78 Million |
| Investing Cash Flow | 169.87 Million | -1.66 Billion | -337.56 Million | -924.77 Million | 551.96 Million | 822.86 Million |
| Investments in PPE | -295.41 Million | -402.45 Million | -601.01 Million | -506.63 Million | -500.79 Million | -262.27 Million |
| Acquisitions | 14.92 Million | 88.44 Million | -153.37 Million | 13.78 Million | -13.94 Million | -583.72 Million |
| Investment purchases | -10.09 Billion | -16.16 Billion | -20.04 Billion | -18.8 Billion | -19.51 Billion | -21.45 Billion |
| Sales/Maturities of investments | 10.46 Billion | 15.45 Billion | 20.19 Billion | 18.59 Billion | 20.62 Billion | 23.11 Billion |
| Other Investing Activities | -65.55 Million | -634.77 Million | 265.67 Million | -219.29 Million | -47.92 Million | 9.72 Million |
| Financing Cash Flow | -419.56 Million | -238.93 Million | 750.66 Million | 184.54 Million | -167.52 Million | -132.67 Million |
| Debt repayment | -14.92 Million | -328.04 Million | -545.62 Million | -379.22 Million | -110.89 Million | -137.13 Million |
| Dividends payments | -298.56 Million | -1.31 Billion | -122.88 Million | -1.41 Billion | -160.98 Million | -240 Million |
| Common Stock Repurchased | -33.81 Million | - | -206.4 Million | - | -8.51 Million | - |
| Common Stock Issuance | - | - | 2.73 Million | - | 119.41 Million | - |
| Other Financing Activities | 10.17 Million | 219.73 Million | 1.62 Billion | 696.29 Million | -6.53 Million | 165.46 Million |
| Accounts receivables | 265.79 Million | -163.67 Million | -245.24 Million | -269.51 Million | 235.09 Million | -20.34 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 37.74 Million | -60.44 Million | -226.8 Million | -65.32 Million | -108.47 Million | -73.14 Million |
| Other working capital | -192.43 Million | - | - | - | - | - |
| Cash at beginning of period | 3.82 Billion | 5.68 Billion | 4.6 Billion | 5.11 Billion | 3.31 Billion | 831.85 Million |
| Cash at end of period | 3.77 Billion | 3.82 Billion | 5.68 Billion | 4.6 Billion | 5.11 Billion | 3.31 Billion |
| Capital Expenditure | -295.41 Million | -402.45 Million | -601.01 Million | -506.63 Million | -500.79 Million | -262.27 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -50.19 Million | -1.85 Billion | 1.07 Billion | -513.1 Million | 1.8 Billion | 2.48 Billion |
| Free Cash Flow | -95.93 Million | -355.96 Million | 64.27 Million | -279.5 Million | 917.06 Million | 1.53 Billion |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -33.42 Million | -4.37 Million | -161.26 Million | -49.64 Million | -1.91 Billion | - |
| Depreciation & Amortization | 123.27 Million | 103.9 Million | 226.23 Million | 122.32 Million | 338.77 Million | - |
| Deferred income taxes | - | - | - | -53.86 Million | 134.45 Million | - |
| Stock-based compensation | 36.3 Million | 29.36 Million | 89.08 Million | 59.72 Million | 89.66 Million | - |
| Change in working capital | -61.14 Million | 309.39 Million | 111.1 Million | -5.86 Million | -224.11 Million | - |
| Other non-cash items | -28.55 Million | -267.12 Million | 121.42 Million | -98.22 Million | 1.62 Billion | - |
| Investing Cash Flow | 253.26 Million | 69.51 Million | 169.87 Million | 100.36 Million | -1.66 Billion | - |
| Investments in PPE | -48.33 Million | -51.56 Million | -295.41 Million | -73.77 Million | -402.45 Million | - |
| Acquisitions | - | - | 14.92 Million | - | 88.44 Million | - |
| Investment purchases | - | - | -10.09 Billion | - | -16.16 Billion | - |
| Sales/Maturities of investments | - | - | 10.46 Billion | - | 15.45 Billion | - |
| Other Investing Activities | 301.59 Million | 121.08 Million | -65.55 Million | 174.13 Million | -634.77 Million | - |
| Financing Cash Flow | -58.32 Million | -196.05 Million | -419.56 Million | -223.51 Million | -238.93 Million | - |
| Debt repayment | -19.51 Million | - | -14.92 Million | -133.15 Million | -328.04 Million | - |
| Dividends payments | -1.6 Million | - | -298.56 Million | -298.56 Million | -1.31 Billion | - |
| Common Stock Repurchased | -13.89 Million | - | -33.81 Million | -33.81 Million | - | - |
| Common Stock Issuance | - | - | - | 225.67 Million | - | - |
| Other Financing Activities | -23.31 Million | -196.05 Million | 10.17 Million | -24.29 Million | 219.73 Million | - |
| Accounts receivables | -141.1 Million | 260.69 Million | 265.79 Million | 5.09 Million | -163.67 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 79.95 Million | 48.69 Million | 37.74 Million | -10.95 Million | -60.44 Million | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 3.77 Billion | 3.73 Billion | 3.82 Billion | - | 5.68 Billion | 5.09 Billion |
| Cash at end of period | 4.01 Billion | 3.73 Billion | 3.77 Billion | 3.73 Billion | 3.82 Billion | 5.09 Billion |
| Capital Expenditure | -48.33 Million | -51.56 Million | -295.41 Million | -73.77 Million | -402.45 Million | - |
| Effect of forex changes on cash | - | - | - | 3.82 Billion | - | - |
| Net cash flow / Change in cash | 231.4 Million | - | -50.19 Million | 3.73 Billion | -1.85 Billion | - |
| Free Cash Flow | -11.87 Million | 119.6 Million | -95.93 Million | -45.46 Million | -355.96 Million | - |
011700
6690
BANL
IBIDF
GLOBAL
BANT